FDA V. BROWN & WILLIAMSON TOBACCO CORP. 529 U.S. 120 (2000) CASE BRIEF

FDA V. BROWN & WILLIAMSON TOBACCO CORP.
529 U.S. 120 (2000)
NATURE OF THE CASE: This was a dispute over an administrative agency’s construction of a statute and Congressional intent.
FACTS: The FDA issued a rule to prevent marketing of tobacco products to young people. The FDA claimed this authority because it had determined that nicotine was a drug and cigarettes were drug delivery devices under the Food, Drug, and Cosmetic Act (FDCA). The Act defined a drug to be any articles other than food intended to affect the structure or function of the body and device as an instrument, apparatus, implement, machine, contrivance that was intended to affect the structure of any function of the body. The tobacco industry disagreed and claimed that the Act precluded an interpretation that it authorized the FDA to regulate tobacco products. The court of appeals agreed with the tobacco companies.

ISSUE:


RULE OF LAW:


HOLDING AND DECISION:


LEGAL ANALYSIS:





Get free access to the entire content for Mac, PC or Online

for 2-3 days and free samples of all kinds of products.

https://bsmsphd.com




© 2007-2016 Abn Study Partner

No comments:

Post a Comment